199 related articles for article (PubMed ID: 37761837)
21. Transcriptional Reactivation of OTX2, RX1 and SIX3 during Reprogramming Contributes to the Generation of RPE Cells from Human iPSCs.
Li P; Sun X; Ma Z; Liu Y; Jin Y; Ge R; Hao L; Ma Y; Han S; Sun H; Zhang M; Li R; Li T; Shen L
Int J Biol Sci; 2016; 12(5):505-17. PubMed ID: 27019633
[TBL] [Abstract][Full Text] [Related]
22. Identification of small activating RNAs that enhance endogenous OCT4 expression in human mesenchymal stem cells.
Wang J; Huang V; Ye L; Bárcena A; Lin G; Lue TF; Li LC
Stem Cells Dev; 2015 Feb; 24(3):345-53. PubMed ID: 25232932
[TBL] [Abstract][Full Text] [Related]
23. Nuclear reprogramming of luminal-like breast cancer cells generates Sox2-overexpressing cancer stem-like cellular states harboring transcriptional activation of the mTOR pathway.
Corominas-Faja B; Cufí S; Oliveras-Ferraros C; Cuyàs E; López-Bonet E; Lupu R; Alarcón T; Vellon L; Iglesias JM; Leis O; Martín ÁG; Vazquez-Martin A; Menendez JA
Cell Cycle; 2013 Sep; 12(18):3109-24. PubMed ID: 23974095
[TBL] [Abstract][Full Text] [Related]
24. Optimal reprogramming factor stoichiometry increases colony numbers and affects molecular characteristics of murine induced pluripotent stem cells.
Tiemann U; Sgodda M; Warlich E; Ballmaier M; Schöler HR; Schambach A; Cantz T
Cytometry A; 2011 Jun; 79(6):426-35. PubMed ID: 21548079
[TBL] [Abstract][Full Text] [Related]
25. Pluripotent reprogramming of fibroblasts by lentiviral mediated insertion of SOX2, C-MYC, and TCL-1A.
Picanço-Castro V; Russo-Carbolante E; Reis LC; Fraga AM; de Magalhães DA; Orellana MD; Panepucci RA; Pereira LV; Covas DT
Stem Cells Dev; 2011 Jan; 20(1):169-80. PubMed ID: 20504151
[TBL] [Abstract][Full Text] [Related]
26. Selective killing of leukemia cells: Yamanaka factors' new trick.
Xie H; Graf T
Stem Cells; 2020 Jul; 38(7):818-821. PubMed ID: 32159910
[TBL] [Abstract][Full Text] [Related]
27. Expression and Functional Analysis of core stemness factors OSKM (OCT4, SOX2, KLF4, and MYC) in Pan-cancer.
Hong L; Hong S; Zhang X
Medicine (Baltimore); 2023 Dec; 102(48):e36433. PubMed ID: 38050242
[TBL] [Abstract][Full Text] [Related]
28. Oct4-enhanced green fluorescent protein transgenic pigs: a new large animal model for reprogramming studies.
Nowak-Imialek M; Kues WA; Petersen B; Lucas-Hahn A; Herrmann D; Haridoss S; Oropeza M; Lemme E; Schöler HR; Carnwath JW; Niemann H
Stem Cells Dev; 2011 Sep; 20(9):1563-75. PubMed ID: 21126163
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-302 increases reprogramming efficiency via repression of NR2F2.
Hu S; Wilson KD; Ghosh Z; Han L; Wang Y; Lan F; Ransohoff KJ; Burridge P; Wu JC
Stem Cells; 2013 Feb; 31(2):259-68. PubMed ID: 23136034
[TBL] [Abstract][Full Text] [Related]
30. The detrimental effects of diabetes on pluripotency determined by KLF4, SOX2, C-MYC and OCT4 immunoreactivity in rat testes.
Aktug H; Uysal A; Yavasoglu A; Oltulu F; Akarca SO; Yilmaz-Dilsiz O; Oktem G
Adv Clin Exp Med; 2013; 22(3):327-35. PubMed ID: 23828673
[TBL] [Abstract][Full Text] [Related]
31. Cellular plasticity in reprogramming, rejuvenation and tumorigenesis: a pioneer TF perspective.
Huyghe A; Trajkova A; Lavial F
Trends Cell Biol; 2024 Mar; 34(3):255-267. PubMed ID: 37648593
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA Replacing Oncogenic Klf4 and c-Myc for Generating iPS Cells via Cationized Pleurotus eryngii Polysaccharide-based Nanotransfection.
Deng W; Cao X; Chen J; Zhang Z; Yu Q; Wang Y; Shao G; Zhou J; Gao X; Yu J; Xu X
ACS Appl Mater Interfaces; 2015 Sep; 7(34):18957-66. PubMed ID: 26269400
[TBL] [Abstract][Full Text] [Related]
33. Facile and efficient reprogramming of ciliary body epithelial cells into induced pluripotent stem cells.
Ni A; Wu MJ; Nakanishi Y; Chavala SH
Stem Cells Dev; 2013 Sep; 22(18):2543-50. PubMed ID: 23635313
[TBL] [Abstract][Full Text] [Related]
34. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
35. Deciphering the roadmap of in vivo reprogramming toward pluripotency.
Chondronasiou D; Martínez de Villarreal J; Melendez E; Lynch CJ; Pozo ND; Kovatcheva M; Aguilera M; Prats N; Real FX; Serrano M
Stem Cell Reports; 2022 Nov; 17(11):2501-2517. PubMed ID: 36270281
[TBL] [Abstract][Full Text] [Related]
36. Gene expression of OCT4, SOX2, KLF4 and MYC (OSKM) induced pluripotent stem cells: identification for potential mechanisms.
Cai Y; Dai X; Zhang Q; Dai Z
Diagn Pathol; 2015 Apr; 10():35. PubMed ID: 25907774
[TBL] [Abstract][Full Text] [Related]
37. NCoR/SMRT co-repressors cooperate with c-MYC to create an epigenetic barrier to somatic cell reprogramming.
Zhuang Q; Li W; Benda C; Huang Z; Ahmed T; Liu P; Guo X; Ibañez DP; Luo Z; Zhang M; Abdul MM; Yang Z; Yang J; Huang Y; Zhang H; Huang D; Zhou J; Zhong X; Zhu X; Fu X; Fan W; Liu Y; Xu Y; Ward C; Khan MJ; Kanwal S; Mirza B; Tortorella MD; Tse HF; Chen J; Qin B; Bao X; Gao S; Hutchins AP; Esteban MA
Nat Cell Biol; 2018 Apr; 20(4):400-412. PubMed ID: 29531310
[TBL] [Abstract][Full Text] [Related]
38. Critical POU domain residues confer Oct4 uniqueness in somatic cell reprogramming.
Jin W; Wang L; Zhu F; Tan W; Lin W; Chen D; Sun Q; Xia Z
Sci Rep; 2016 Feb; 6():20818. PubMed ID: 26877091
[TBL] [Abstract][Full Text] [Related]
39. Direct Reprogramming of Human Primordial Germ Cells into Induced Pluripotent Stem Cells: Efficient Generation of Genetically Engineered Germ Cells.
Bazley FA; Liu CF; Yuan X; Hao H; All AH; De Los Angeles A; Zambidis ET; Gearhart JD; Kerr CL
Stem Cells Dev; 2015 Nov; 24(22):2634-48. PubMed ID: 26154167
[TBL] [Abstract][Full Text] [Related]
40. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
